This is a visual explainer based on the Wikipedia article on Anorectic. Read the full source article here. (opens in new tab)

The Appetite Equation

A comprehensive exploration of substances that modulate appetite, from historical applications to modern pharmacological insights into anorectic agents.

What are Anorectics? 👇 Explore Agents 💊

Dive in with Flashcard Learning!


When you are ready...
🎮 Play the Wiki2Web Clarity Challenge Game🎮

Introduction to Anorectics

Defining Appetite Control

An anorectic is a pharmacological agent designed to reduce appetite, thereby leading to decreased food consumption and subsequent weight loss. These substances exert their effects primarily by influencing the central nervous system or specific neurotransmitters, inducing a sensation of fullness or diminishing the drive to eat.

Mechanisms of Action

The understanding of anorexiant effects is critical for developing interventions in weight management and related health conditions. Anorectic mechanisms can be diverse, involving hormonal regulation and neural signaling. Key hormones such as ghrelin, leptin, and peptide YY play roles in appetite control, complemented by neurotransmitters like serotonin and dopamine within the central nervous system that significantly regulate food intake.

Orexigenic vs. Anorectic

Conversely, substances that stimulate appetite are termed orexigenic. The term "anorectic" itself originates from the Greek words "an-" (without) and "orexis" (appetite), literally meaning "without appetite." These agents are also referred to as anorexigenic or appetite suppressants.

Historical Context

Early Clinical Use and Diversion

Historically, anorectic drugs were employed for short-term clinical management of obesity. Some were available over-the-counter, often formulated with natural ingredients like green tea extract and fucoxanthin. Many of these early suppressants were stimulants derived from the phenethylamine family, closely related to amphetamine.

Wartime and Post-War Applications

During World War II, amphetamines such as Pervitin were issued to soldiers by German and Finnish militaries to combat fatigue. Similarly, the UK and US militaries received substantial quantities of Benzedrine tablets. Following the war, surplus amphetamines were channeled into the black market and civilian use, including as appetite suppressants, before widespread bans were enacted due to safety concerns like addiction, tachycardia, and hypertension.

Public Health Concerns

Cardiovascular Risks

Epidemics of severe cardiovascular conditions, including fatal pulmonary hypertension and heart valve damage, were linked to pharmaceutical anorectic agents. This led to the market withdrawal of drugs like aminorex in the 1960s and fenfluramine (as part of Fen-phen) in the 1990s.

Neurological and Regulatory Issues

The association of phenylpropanolamine with hemorrhagic stroke prompted the U.S. FDA to request its withdrawal in 2000. Concerns regarding ephedrine's use as a precursor in methamphetamine manufacture also contributed to regulatory actions, although its ban in dietary supplements was later challenged. These events underscore the complex balance between therapeutic effects and potential adverse outcomes.

Non-Pharmacological Approaches

The Role of Water Consumption

Research has explored non-pharmacological methods for appetite suppression, notably the consumption of water. Studies suggest that drinking approximately 500 mL of water 30 minutes prior to meals may contribute to modest weight loss over a 12-week period in adults. This simple intervention appears to aid in appetite suppression by increasing satiety.

Refeeding Syndrome

Metabolic Disturbances

Refeeding syndrome (RFS) is a critical metabolic disturbance occurring when nutrition is reintroduced to individuals who have been starved, severely malnourished, or are metabolically stressed due to illness. Rapid reintroduction of nutrients can lead to potentially fatal shifts in fluid and electrolytes, including low serum concentrations of potassium, magnesium, and phosphate.

Risk Factors and Consequences

RFS typically manifests after 4-5 days without adequate caloric intake. Individuals with substance abuse disorders who are reintroducing normal eating patterns after a period of malnutrition are at increased risk. The resulting electrolyte imbalances can trigger severe neurological, cardiac, neuromuscular, and hematologic symptoms.

Anorectic Agents: A Detailed List

Central Nervous System Stimulants

Many anorectic agents function as stimulants, primarily affecting the central nervous system. These are often classified under the Anatomical Therapeutic Chemical (ATC) Classification System code A08AA.

The following are listed as centrally-acting antiobesity preparations:

  • Amfepramone (also known as diethylpropion)
  • Bupropion and naltrexone (combination)
  • Cathine
  • Clobenzorex
  • Dexfenfluramine (withdrawn)
  • Ephedrine (combinations)
  • Etilamfetamine
  • Fenfluramine (withdrawn due to cardiovascular risks)
  • Lorcaserin (withdrawn in the US due to cancer risk)
  • Mazindol
  • Mefenorex
  • Phentermine
  • Sibutramine (withdrawn in some countries)
  • Topiramate

Indicates drugs withdrawn from the market.

MeSH and Other Agents

The Medical Subject Headings (MeSH) index and other pharmacological data identify a broader range of compounds with appetite suppressant activity.

Agents listed by MeSH:

  • Benfluorex (removed from market)
  • Butenolide
  • Diethylpropion
  • FG-7142
  • Phenmetrazine (withdrawn in some countries)
  • Phentermine
  • Phenylpropanolamine
  • Pyroglutamyl-histidyl-glycine
  • Sibutramine

Other compounds with known appetite suppressant activity:

  • Amphetamine-Dextroamphetamine (e.g., Adderall)
  • Amphetamine sulfate (e.g., Evekeo)
  • Methylphenidate
  • Cocaine
  • Caffeine
  • Glucomannan
  • Leptin
  • Lisdexamfetamine (e.g., Vyvanse)
  • Methamphetamine hydrochloride (e.g., Desoxyn)
  • Nicotine
  • Liraglutide (e.g., Saxenda)
  • Semaglutide (e.g., Ozempic/Wegovy)
  • Tirzepatide (e.g., Mounjaro/Zepbound)
  • Metformin
  • Opiates/opioids (e.g., heroin, morphine, codeine, oxycodone, fentanyl)

Indicates drugs withdrawn from the market or with significant safety concerns.

Broader Pharmacological Classes

Anorectic effects are also observed within broader drug classes, including those targeting specific receptor systems or metabolic pathways.

Stimulants: Amphetamines and phenethylamines (e.g., 4-Methylamphetamine, Amfepramone, Amphetamine, Cathine, Clobenzorex, Dextroamphetamine, Ephedrine, Fenproporex, Lisdexamfetamine, Mefenorex, Methamphetamine, Phentermine).

Adrenergic agonists: (e.g., Albuterol, Clenbuterol§, Ephedrine, Synephrine, Yohimbine).

Cannabinoid receptor antagonists: (e.g., Rimonabant, Otenabant§).

GLP-1, GIP, and Glucagon agonists: (e.g., Semaglutide, Tirzepatide, Liraglutide, Retatrutide).

DACRAs (Dual Amylin and Calcitonin Receptor Agonists): (e.g., Cagrilintide).

5-HT2C receptor agonists: (e.g., Lorcaserin).

Absorption inhibitors: (e.g., Orlistat, Cetilistat).

Uncouplers: (e.g., 2,4-Dinitrophenol).

Other agents: Metformin, Naltrexone, Topiramate, Zonisamide, Water.

Phase III clinical trial. § Never progressed beyond early clinical trials. Withdrawn from market.

References

Test Your Knowledge

Interactive Quiz

Assess your understanding of anorectic agents and their mechanisms with our interactive quiz.

Teacher's Corner

Edit and Print this course in the Wiki2Web Teacher Studio

Edit and Print Materials from this study in the wiki2web studio
Click here to open the "Anorectic" Wiki2Web Studio curriculum kit

Use the free Wiki2web Studio to generate printable flashcards, worksheets, exams, and export your materials as a web page or an interactive game.

True or False?

Test Your Knowledge!

Gamer's Corner

Are you ready for the Wiki2Web Clarity Challenge?

Learn about anorectic while playing the wiki2web Clarity Challenge game.
Unlock the mystery image and prove your knowledge by earning trophies. This simple game is addictively fun and is a great way to learn!

Play now

References

References

  1.  fi:Pervitiini
  2.  ATC/DDD Index
A full list of references for this article are available at the Anorectic Wikipedia page

Feedback & Support

To report an issue with this page, or to find out ways to support the mission, please click here.

Disclaimer

Important Notice

This page was generated by an Artificial Intelligence and is intended for informational and educational purposes only. The content is based on a snapshot of publicly available data from Wikipedia and may not be entirely accurate, complete, or up-to-date.

This is not medical advice. The information provided on this website is not a substitute for professional medical consultation, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The creators of this page are not responsible for any errors or omissions, or for any actions taken based on the information provided herein.